MENU

SRDX Surmodics Forecast, Technical & Fundamental Analysis

a provider of surface modification and in vitro diagnostic technologies to the healthcare industry

SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SRDX is expected to report earnings to fall 51.37% to -11 cents per share on January 30

Surmodics SRDX Stock Earnings Reports
Q4'24
Est.
$-0.12
Q3'24
Beat
by $0.07
Q2'24
Beat
by $0.07
Q1'24
Beat
by $0.42
Q4'23
Beat
by $0.27
The last earnings report on November 06 showed earnings per share of -23 cents, beating the estimate of -31 cents. With 22.82K shares outstanding, the current market capitalization sits at 397.04M.
A.I. Advisor
published General Information

General Information

a provider of surface modification and in vitro diagnostic technologies to the healthcare industry

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
9924 West 74th Street
Phone
+1 952 500-7000
Employees
376
Web
https://www.surmodics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

SRDX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SRDX has been loosely correlated with PXMBF. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SRDX jumps, then PXMBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRDX
1D Price
Change %
SRDX100%
-0.12%
PXMBF - SRDX
41%
Loosely correlated
N/A
LIVN - SRDX
37%
Loosely correlated
-0.42%
TMDX - SRDX
30%
Poorly correlated
+2.31%
NARI - SRDX
28%
Poorly correlated
-1.04%
ME - SRDX
27%
Poorly correlated
-2.99%
More